Patents by Inventor Julius Gudmundsson

Julius Gudmundsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sequence Variants Associated with Prostate Specific Antigen Levels
    Publication number: 20170191134
    Abstract: Certain sequence variants have been found to be useful for correcting Prostate Specific Antigen levels in humans. The invention provides diagnostic applications based on such correction, including methods of diagnosis of prostate cancer.
    Type: Application
    Filed: August 8, 2016
    Publication date: July 6, 2017
    Applicant: deCODE genetics ehf
    Inventors: Julius Gudmundsson, Daniel Gudbjartsson, Patrick Sulem
  • Genetic variants contributing to risk of prostate cancer
    Patent number: 8865400
    Abstract: The present invention is characterized by certain genetic variants being susceptibility variants for prostate cancer. The invention relates to methods of determining increased susceptibility to prostate cancer, as well as methods of determining decreased susceptibility to prostate cancer, using such variants. The invention further relates to kits for determining a susceptibility to prostate cancer.
    Type: Grant
    Filed: February 7, 2008
    Date of Patent: October 21, 2014
    Assignee: deCODE Genetics ehf.
    Inventors: Julius Gudmundsson, Patrick Sulem
  • GENETIC VARIANTS ON CHR 11Q AND 6Q AS MARKERS FOR PROSTATE AND COLORECTAL CANCER PREDISPOSITION
    Publication number: 20140248615
    Abstract: It has been discovered that certain polymorphic markers on chromosome 6 and chromosome 11 are indicative of a susceptibility to prostate cancer and colon cancer. The invention describes diagnostic applications for determining a susceptibility to cancer using such markers, as well as kits for use in such applications.
    Type: Application
    Filed: March 6, 2014
    Publication date: September 4, 2014
    Applicant: deCODE Genetics ehf.
    Inventors: Steinunn Thorlacius, Patrick Sulem, Julius Gudmundsson
  • Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
    Patent number: 8697360
    Abstract: It has been discovered that certain polymorphic markers on chromosome 6 and chromosome 11 are indicative of a susceptibility to prostate cancer and colon cancer. The invention describes diagnostic applications for determining a susceptibility to cancer using such markers, as well as kits for use in such applications.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: April 15, 2014
    Assignee: deCODE Genetics ehf.
    Inventors: Steinunn Thorlacius, Patrick Sulem, Julius Gudmundsson
  • GENETIC VARIANTS USEFUL FOR RISK ASSESSMENT OF THYROID CANCER
    Publication number: 20140087961
    Abstract: The invention discloses genetic variants that have been determined to be susceptibility variants of thyroid cancer. Methods of disease management, including methods of determining susceptibility to thyroid cancer, methods of predicting response to therapy and methods of predicting prognosis of thyroid cancer using such variants are described. The invention further relates to kits useful in the methods of the invention.
    Type: Application
    Filed: March 16, 2012
    Publication date: March 27, 2014
    Applicants: ILLUMINA INC., deCODE Genetics ehf.
    Inventors: Patrick Sulem, Julius Gudmundsson
  • GENETIC VARIANTS USEFUL FOR RISK ASSESSMENT OF THYROID CANCER
    Publication number: 20130273543
    Abstract: The invention discloses genetic variants that have been determined to be susceptibility variants of thyroid cancer. Methods of disease management, including methods of determining susceptibility to thyroid cancer, methods of predicting response to therapy and methods of predicting prognosis of thyroid cancer using such variants are described. The invention further relates to kits useful in the methods of the invention.
    Type: Application
    Filed: December 20, 2011
    Publication date: October 17, 2013
    Applicant: deCODE Genetics ehf.
    Inventors: Julius Gudmundsson, Patrick Sulem
  • Sequence Variants Associated with Prostate Specific Antigen Levels
    Publication number: 20120150032
    Abstract: Certain sequence variants have been found to be useful for correcting Prostate Specific Antigen levels in humans. The invention provides diagnostic applications based on such correction, including methods of diagnosis of prostate cancer.
    Type: Application
    Filed: December 13, 2010
    Publication date: June 14, 2012
    Inventors: Julius Gudmundsson, Daniel Gudbjartsson, Patrick Sulem
  • Genetic Variants Useful for Risk Assessment of Thyroid Cancer
    Publication number: 20110287946
    Abstract: The invention discloses genetic variants that have been determined to be susceptibility variants of thyroid cancer. Methods of disease management, including methods of determining susceptibility to thyroid cancer, methods of predicting response to therapy and methods of predicting prognosis of thyroid cancer using such variants are described. The invention further relates to kits useful in the methods of the invention.
    Type: Application
    Filed: November 26, 2009
    Publication date: November 24, 2011
    Applicant: deCODE genetics ehf.
    Inventors: Julius Gudmundsson, Patrick Sulem, Daniel Gudbjartsson
  • Genetic Variants Useful for Risk Assessment of Thyroid Cancer
    Publication number: 20110230366
    Abstract: The invention discloses genetic variants that have been determined to be susceptibility variants of thyroid cancer. Methods of disease management, including determining increased susceptibility to thyroid cancer, methods of predicting response to therapy and methods of predicting prognosis of thyroid cancer using such variants are described. The invention further relates to kits useful in the methods of the invention.
    Type: Application
    Filed: August 12, 2009
    Publication date: September 22, 2011
    Applicant: deCODE Genetics ehf.
    Inventors: Julius Gudmundsson, Daniel Gudbjartsson, Patrick Sulem
  • Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
    Publication number: 20110053281
    Abstract: It has been discovered that certain polymorphic markers on chromosome 6 and chromosome 11 are indicative of a susceptibility to prostate cancer and colon cancer. The invention describes diagnostic applications for determining a susceptibility to cancer using such markers, as well as kits for use in such applications.
    Type: Application
    Filed: November 26, 2008
    Publication date: March 3, 2011
    Inventors: Steinunn Thorlacius, Patrick Sulem, Julius Gudmundsson
  • Genetic Variants Contributing to Risk of Prostate Cancer
    Publication number: 20110020320
    Abstract: It has been discovered that certain genetic markers are associated with risk of prostate cancer. The invention describes diagnostic applications for determining a susceptibilty to prostate cancer using such markers, including methods, uses, kits, and computer applications.
    Type: Application
    Filed: May 10, 2010
    Publication date: January 27, 2011
    Applicant: deCODE Genetics ehf.
    Inventors: Julius Gudmundsson, Patrick Sulem
  • GENETIC VARIANTS CONTRIBUTING TO RISK OF PROSTATE CANCER
    Publication number: 20100041037
    Abstract: The present invention is characterised by certain genetic variants being susceptibility variants for prostate cancer. The invention relates to methods of determining increased susceptibility to prostate cancer, as well as methods of determining decreased susceptibility to prostate cancer, using such variants. The invention further relates to kits for determining a susceptibility to prostate cancer.
    Type: Application
    Filed: February 7, 2008
    Publication date: February 18, 2010
    Inventors: Julius Gudmundsson, Patrick Sulem
  • Variants at chr8q24.21 confer risk of cancer
    Publication number: 20090317799
    Abstract: A locus on chromosome 8q24.21 has been demonstrated to play a major role in particular forms of cancer. It has been discovered that certain markers and haplotypes are indicative of a susceptibility to particular cancers. Diagnostic applications for identifying susceptibilty to cancer are described.
    Type: Application
    Filed: May 18, 2006
    Publication date: December 24, 2009
    Applicant: deCODE genetics ehf.
    Inventors: Laufey Amundadottir, Julius Gudmundsson, Patrick Sulem